Maravai Lifesciences Holdings (MRVI) Other Operating Expenses (2020 - 2025)

Maravai Lifesciences Holdings' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $25.8 million for Q4 2025.

• On a quarterly basis, Other Operating Expenses rose 128.9% year-over-year to $25.8 million in Q4 2025; TTM through Mar 2026 was $96.1 million, a 55.34% decrease from a year earlier, with the FY2025 full-year figure at $68.9 million, down 58.02% from the prior year.
• Other Operating Expenses rose to $25.8 million in Q4 2025 per MRVI's latest filing, from $60000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $154.1 million in Q3 2024 and bottomed at -$117.0 million in Q4 2023.
• The 5-year median for Other Operating Expenses is $33.7 million (2023), against an average of $29.2 million.
• Across the five-year window, Other Operating Expenses jumped 947.26% in 2021 and tumbled 99.96% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $11.2 million in 2021, then soared by 163.99% to $29.7 million in 2022, then sank by 493.96% to -$117.0 million in 2023, then surged by 109.64% to $11.3 million in 2024, then jumped by 128.9% to $25.8 million in 2025.
• Per Business Quant, the three latest MRVI Other Operating Expenses figures stand at $25.8 million (Q4 2025), $60000.0 (Q3 2025), and $70.2 million (Q2 2025).